Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Simcere Enters $50 Million Deal for China Rights to Novel Insomnia Therapy

publication date: Nov 16, 2022

Nanjing Simcere Pharma acquired greater China rights to a novel insomnia therapy from Idorsia in a $50 million agreement. Idorsia is a Swiss pharma that develops small molecule therapies. Daridorexant is a dual orexin receptor antagonist that blocks the binding of orexins, which are wake-promoting neuropeptides, without inhibiting brain activity. Idorsia says the therapy provides sleep without causing daytime sleepiness. Simcere will make a $30 million upfront payment, a $20 million payment upon China approval, plus sales milestones and royalties. More details....

Stock Symbol: (HK: 2096) (SIX: IDIA)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here